- Home
- PRFX vs GCTK Comparison
PRFX vs GCTK Comparison
Compare PRFX & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRFX
- GCTK
- Stock Information
- Founded
- PRFX 2007
- GCTK 2001
- Country
- PRFX Israel
- GCTK United States
- Employees
- PRFX N/A
- GCTK N/A
- Industry
- PRFX Biotechnology: Pharmaceutical Preparations
- GCTK Medical/Dental Instruments
- Sector
- PRFX Health Care
- GCTK Health Care
- Exchange
- PRFX Nasdaq
- GCTK Nasdaq
- Market Cap
- PRFX 3.3M
- GCTK 3.3M
- IPO Year
- PRFX 2020
- GCTK N/A
- Fundamental
- Price
- PRFX $1.63
- GCTK $4.87
- Analyst Decision
- PRFX Hold
- GCTK
- Analyst Count
- PRFX 1
- GCTK 0
- Target Price
- PRFX N/A
- GCTK N/A
- AVG Volume (30 Days)
- PRFX 8.7M
- GCTK 478.1K
- Earning Date
- PRFX 09-16-2025
- GCTK 08-14-2025
- Dividend Yield
- PRFX N/A
- GCTK N/A
- EPS Growth
- PRFX N/A
- GCTK N/A
- EPS
- PRFX N/A
- GCTK N/A
- Revenue
- PRFX N/A
- GCTK N/A
- Revenue This Year
- PRFX N/A
- GCTK N/A
- Revenue Next Year
- PRFX N/A
- GCTK N/A
- P/E Ratio
- PRFX N/A
- GCTK N/A
- Revenue Growth
- PRFX N/A
- GCTK N/A
- 52 Week Low
- PRFX $1.25
- GCTK $4.22
- 52 Week High
- PRFX $16.63
- GCTK $3,756.00
- Technical
- Relative Strength Index (RSI)
- PRFX 53.13
- GCTK 42.68
- Support Level
- PRFX $1.34
- GCTK $4.25
- Resistance Level
- PRFX $1.92
- GCTK $5.88
- Average True Range (ATR)
- PRFX 0.27
- GCTK 0.47
- MACD
- PRFX -0.02
- GCTK 0.01
- Stochastic Oscillator
- PRFX 13.05
- GCTK 36.93
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.